Chemistry Wealth Management’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History
Bought
Maintained
Sold
Other funds holding VEA
Chemistry Wealth Management's VEA Position: Q1 2026 in Review
Chemistry Wealth Management sold out of Vanguard FTSE Developed Markets ETF (VEA) in Q1 2026, closing a stake of 5,385 shares — an estimated $336K sold.
Chemistry Wealth Management first reported a position in VEA in Q4 2021 and held it in 9 quarters. The position peaked at $410K in Q4 2021. 2,894 funds tracked by Wall St. Rank hold VEA as of Q1 2026.
- Chemistry Wealth Management reported no remaining Vanguard FTSE Developed Markets ETF position as of Q1 2026 after selling out during the quarter.
- Chemistry Wealth Management sold 5,385 Vanguard FTSE Developed Markets ETF shares in Q1 2026, an estimated $336K.
- Chemistry Wealth Management first reported a position in Vanguard FTSE Developed Markets ETF in Q4 2021 and held it in 9 quarters.
- Chemistry Wealth Management's Vanguard FTSE Developed Markets ETF position peaked at $410K in Q4 2021.
- 2,894 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q1 2026.
Based on Chemistry Wealth Management's 13F filing for Q1 2026, filed 9 Apr 2026.